OBJECTIVE: To determine mortality rates after a first lower limb amputation and explore the rates for different subpopulations. METHODS: Retrospective cohort study of all people who underwent a first amputation at or proximal to transtibial level, in an area of 1.7 million people. Analysis with Kaplan-Meier curves and Log Rank tests for univariate associations of psycho-social and health variables. Logistic regression for odds of death at 30-days, 1-year and 5-years. RESULTS: 299 people were included. Median time to death was 20.3 months (95%CI: 13.1; 27.5). 30-day mortality = 22%; odds of death 2.3 times higher in people with history of cerebrovascular disease (95%CI: 1.2; 4.7, P = 0.016). 1 year mortality = 44%; odds of death 3.5 times higher for people with renal disease (95%CI: 1.8; 7.0, P < 0.001). 5-years mortality = 77%; odds of death 5.4 times higher for people with renal disease (95%CI: 1.8; 16.0,P = 0.003). Variation in mortality rates was most apparent in different age groups; people 75-84 years having better short term outcomes than those younger and older. CONCLUSIONS: Mortality rates demonstrated the frailty of this population, with almost one quarter of people dying within 30-days, and almost half at 1 year. People with cerebrovascular had higher odds of death at 30 days, and those with renal disease and 1 and 5 years, respectively.
OBJECTIVE: To determine mortality rates after a first lower limb amputation and explore the rates for different subpopulations. METHODS: Retrospective cohort study of all people who underwent a first amputation at or proximal to transtibial level, in an area of 1.7 million people. Analysis with Kaplan-Meier curves and Log Rank tests for univariate associations of psycho-social and health variables. Logistic regression for odds of death at 30-days, 1-year and 5-years. RESULTS: 299 people were included. Median time to death was 20.3 months (95%CI: 13.1; 27.5). 30-day mortality = 22%; odds of death 2.3 times higher in people with history of cerebrovascular disease (95%CI: 1.2; 4.7, P = 0.016). 1 year mortality = 44%; odds of death 3.5 times higher for people with renal disease (95%CI: 1.8; 7.0, P < 0.001). 5-years mortality = 77%; odds of death 5.4 times higher for people with renal disease (95%CI: 1.8; 16.0,P = 0.003). Variation in mortality rates was most apparent in different age groups; people 75-84 years having better short term outcomes than those younger and older. CONCLUSIONS: Mortality rates demonstrated the frailty of this population, with almost one quarter of people dying within 30-days, and almost half at 1 year. People with cerebrovascular had higher odds of death at 30 days, and those with renal disease and 1 and 5 years, respectively.
Authors: Trung T Nguyen; William R Wolter; Bowen Anderson; Valerie A Schroeder; Ming Gao; Major Gooyit; Mark A Suckow; Mayland Chang Journal: ACS Pharmacol Transl Sci Date: 2020-02-24
Authors: Betiel K Fesseha; Christopher J Abularrage; Kathryn F Hines; Ronald Sherman; Priscilla Frost; Susan Langan; Joseph Canner; Kendall C Likes; Sayed M Hosseini; Gwendolyne Jack; Caitlin W Hicks; Swaytha Yalamanchi; Nestoras Mathioudakis Journal: Diabetes Care Date: 2018-04-16 Impact factor: 19.112
Authors: D C Norvell; M L Thompson; E J Boyko; G Landry; A J Littman; W G Henderson; A P Turner; C Maynard; K P Moore; J M Czerniecki Journal: Br J Surg Date: 2019-03-13 Impact factor: 6.939
Authors: Eric S Wise; William G McMaster; Kelly Williamson; Justine E Wergin; Kyle M Hocking; Colleen M Brophy Journal: Ann Vasc Surg Date: 2015-11-23 Impact factor: 1.466
Authors: Trung T Nguyen; Derong Ding; William R Wolter; Matthew M Champion; Dusan Hesek; Mijoon Lee; Rocio L Pérez; Valerie A Schroeder; Mark A Suckow; Shahriar Mobashery; Mayland Chang Journal: Eur J Pharmacol Date: 2018-07-19 Impact factor: 4.432